VIGL

Vigil Neuroscience (VIGL)

About Vigil Neuroscience (VIGL)

Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.

Details

Daily high

$2.18

Daily low

$2.02

Price at open

$2.12

52 Week High

$6.06

52 Week Low

$1.49

Market cap

82.6M

Dividend yield

0.00%

Volume

78,357

Avg. volume

220,089

P/E ratio

-.98

Vigil Neuroscience News